Pharma makes hundreds of billions of dollars with government-subsidized Medicaid: buying their overprescribed psychiatric drugs
WHILE YOUR three-part series exposed a broken disability system and the difficult choices being made by today’s underclass, it did not mention the biggest welfare recipient of them all — the pharmaceutical corporations. They make hundreds of billions of dollars with government-subsidized Medicaid insurance buying their overprescribed psychiatric medications — drugs that are systematically promoted through sophisticated, but scientifically disputable, public relations campaigns.
Corporations work with the field of biological psychiatry to create huge markets for their medications for ADHD and bipolar and depressive disorders. While these medications are hyped as being a cure for mental disorders, their dangerous side effects and long-term consequences are underreported. Sometimes they can even create or perpetuate the very mental disorders that they are supposed to cure.